HomeQuestion

What is your treatment approach for a pediatric patient with relapsed histiocytic sarcoma, after prior response to a MEK inhibitor and clofarabine?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?

How do you choose between the different available CAR-T cell therapy products for the treatment of relapsed Ph-negative ALL?

How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?

What resources/ancillary staff do you utilize for school re-entry after cancer treatment to decrease anxiety, improve self-confidence, and support emotional functioning?

How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.